Journal for ImmunoTherapy of Cancer (Nov 2023)
1050 Human stem cell derived dendritic cells provide a physiologically relevant system to evaluate the pharmacology of a FLT3L-Fc fusion protein for cancer immunotherapy
Abstract
No abstracts available.